I have a spreadsheet tracking the performance of NTA (pre and post tax) and share price. What has happened is TEK opened at around a 9.5% premium and as of 31/5/20 was at a 15% discount. This has resulted in the under performance you discuss. However, performance based on NTA is very different. Numbers below:
Date Share price Pre-tax NTA Post-tax NTA 1 31/1/17 23c 20.8c 20.8c 2 31/5/20 25c 28.9c 31.9c
NTA has provided a 10.37% pa return pre tax and 13.69% pa return post tax (based on 31/5/20). Share price for this date has only provided 2.53% pa return.
This shows the effect share price premiums and discounts can have on performance of an LIC. However, I purchased TEK based on a long term hold. Therefore, I am more interested in the NTA performance as this is the underlying performance of TEK. The underlying performance looks good (ASX200 TR was 4.77% pa over the same time). Hopefully, with time the market will realise this and close the discount.
- Forums
- ASX - By Stock
- Thorney making the first move
TEK
thorney technologies ltd
Add to My Watchlist
1.08%
!
9.2¢

I have a spreadsheet tracking the performance of NTA (pre and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
-0.001(1.08%) |
Mkt cap ! $34.76M |
Open | High | Low | Value | Volume |
9.4¢ | 9.4¢ | 9.2¢ | $5.302K | 57.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 160000 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 160000 | 0.092 |
1 | 25903 | 0.091 |
2 | 263695 | 0.090 |
2 | 57000 | 0.089 |
2 | 149007 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 200000 | 1 |
0.095 | 230000 | 2 |
0.100 | 163341 | 3 |
0.110 | 30000 | 1 |
0.115 | 235000 | 3 |
Last trade - 11.04am 26/06/2025 (20 minute delay) ? |
Featured News
TEK (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online